Vital Therapies reported $0 in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Biomarin Pharmaceutical BMRN:US $ 1078.09M 0.98M
Epizyme EPZM:US $ 231.83M 640K
Insmed INSM:US $ 571.41M 8.55M
Mirati Therapeutics MRTX:US $ 0M 0M
Omeros OMER:US $ 313.02M 433K
Quidel QDEL:US $ 0M 0M
Revance Therapeutics RVNC:US $ 280.32M 0.32M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
United Therapeutics UTHR:US $ 800M 0M
Xoma XOMA:US $ 0 0